Search
Gyre Therapeutics Inc
GYREAdd to Watchlist
5.650USD
-0.340-5.68%
Close 07-29 16:00（ET）Quotes delayed by 15 min
516.05MMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025Q3
By BusinessUSD
Name
Revenue
Proportion
ETUARY
27.69M
90.61%
Etorel
1.54M
5.05%
Contiva
1.25M
4.07%
Other Products
81.00K
0.27%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
ETUARY
27.69M
90.61%
Etorel
1.54M
5.05%
Contiva
1.25M
4.07%
Other Products
81.00K
0.27%